AMETEK, Inc. — Q2 2023 Form 10-Q
Reporting period: Three and six months ended June 30, 2023. Unaudited consolidated results; comparisons are with the corresponding 2022 periods unless stated otherwise.
Business context and results
AMETEK operates through Electronic Instruments Group (EIG) and Electromechanical Group (EMG). Management reported record second-quarter sales, operating income, operating margin, net income, diluted EPS and backlog. Growth reflected organic sales, acquisitions and Operational Excellence initiatives.
| Metric | Q2 2023 | Q2 2022 | First half 2023 | First half 2022 |
|---|---|---|---|---|
| Net sales | $1,646.1 million (+8.7%) | $1,514.6 million | $3,243.2 million (+9.1%) | $2,973.1 million |
| Operating income | $418.8 million (+14.8%) | $364.8 million | $824.3 million (+14.8%) | $718.1 million |
| Operating margin | 25.4% | 24.1% | 25.4% | 24.2% |
| Net income | $324.2 million (+14.8%) | $282.4 million | $630.0 million (+13.5%) | $554.8 million |
| Diluted EPS | $1.40 (+14.8%) | $1.22 | $2.72 (+13.8%) | $2.39 |
| Operating cash flow | Not stated for quarter | Not stated for quarter | $721.8 million | $437.2 million |
Performance, cash flow and financial position
- Q2 sales increased 5% organically and 4% from acquisitions. First-half sales rose 7% organically and 3% from acquisitions, offset in part by a 1% unfavorable foreign-currency effect.
- Q2 segment operating margin was 26.9%, up from 25.7%. EIG sales rose 10.3% and segment margin improved to 27.1%; EMG sales rose 5.2% and margin was 26.6%, including dilution from the Bison acquisition.
- First-half free cash flow, defined by the company as operating cash flow less capital expenditures, was $673.9 million, versus $384.7 million. EBITDA, a company-presented non-GAAP measure, was $977.3 million versus $877.2 million. Operating cash flow benefited from higher net income and improved working-capital management.
- Cash and cash equivalents were $605.6 million at June 30, 2023, up from $345.4 million at year-end 2022. Total debt, net was $2,191.7 million, down from $2,385.0 million. Available revolving-credit capacity was $2,969.9 million, including the accordion feature. The company reported compliance with debt covenants.
- Current assets were $2,899.6 million and current liabilities $1,341.2 million. Customer advance payments were $382.6 million in current liabilities. Inventory was $1,107.8 million, up from $1,044.3 million at year-end.
- First-half investing cash use was $150.0 million, including $99.3 million, net of cash acquired, for Bison. Dividends paid were $115.1 million; the quarterly dividend was increased 14% to $0.25 per share. Share repurchases were $6.5 million, compared with $331.4 million in the first half of 2022.
Outlook, risks and unusual items
- No quantified full-year earnings or revenue guidance is provided in the filing. Management said record backlog, the full-year contribution of 2022 acquisitions, Bison and ongoing Operational Excellence initiatives are expected to benefit the remainder of 2023.
- Management cited elevated material-cost inflation, supply-chain constraints and global economic uncertainty. It expects material inflation to remain elevated through 2023 and anticipates pricing actions to mitigate pressure; it is maintaining higher inventories and seeking alternative suppliers.
- Q2 orders increased 0.6% year over year, with organic orders down; backlog reached a record $3,441.9 million at June 30, up 6.9% from December 31, 2022. First-half orders rose 3.6%, also including an organic decrease. Remaining performance obligations due beyond one year were $573.0 million and are expected to be substantially satisfied within two to three years.
- Bison’s March 2023 acquisition had an immaterial impact on reported results through June 30. EMG’s first-half 2022 comparison included a $7.1 million facility-sale gain; lower pension income contributed to higher other expense in 2023.
- Environmental reserves were $41.1 million. Management stated that reasonably possible remediation-cost variances are not expected to materially affect results, financial position or cash flows. AMETEK is named as a potentially responsible party at 13 non-owned sites. It also faces asbestos-related lawsuits; management reported no judgments to date and said certain claims are indemnified by a seller.
- Gross uncertain tax benefits were $191.1 million, of which $140.3 million would affect the effective tax rate if recognized. The company identifies acquisition integration, international operations and supply chains, raw-material availability, regulation, competition, liquidity and general economic conditions among forward-looking risks.
Important facts for investors to verify
- Whether organic order trends and record backlog convert into sales, and how backlog and order growth evolve.
- Whether pricing offsets inflation and supply-chain costs without weakening demand or margins; also monitor inventory levels.
- Acquisition integration and EMG margin performance, particularly the effect of Bison and the full-year contribution of prior acquisitions.
- Cash-flow and working-capital trends, debt reduction, borrowing capacity and the sustainability of capital returns.
- Potential outcomes and reserve adequacy for uncertain tax positions, environmental matters and litigation.
- Management’s qualitative 2023 outlook is not a numeric forecast; compare subsequent filings for any quantified guidance or changes in assumptions.